Increasing awareness about the health benefits of Vitamin K supplementation among consumers is driving the growth of the Vitamin K market. Additionally, the rising prevalence of chronic diseases such as osteoporosis and cardiovascular diseases is boosting the demand for Vitamin K supplements. Moreover, the growing aging population worldwide is creating a favorable environment for the expansion of the Vitamin K market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product Type, Route of Administration, Application |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | BASF SE, Lonza Group, Glanbia Plc, ADM, Farbest Brands, SternVitamin & Co. K.G., Adisseo, Rabar Pty, DSM, Kappa Bioscience, Livealth Biopharma, NattoPharma |
The stringent regulatory requirements for the approval of Vitamin K supplements are posing a significant restraint to market growth. Additionally, the lack of awareness about Vitamin K deficiency and its health implications among consumers in developing regions is hindering the market growth potential.